
Sign up to save your podcasts
Or


Dr. Geo speaks with cancer immunologist Matthew Halpert, PhD about Immunocine, a dendritic-cell platform that “double-loads” patient-specific tumor signals to trigger a strong, physiologic immune response. Discussion includes mechanism, prostate cancer cases, how it can complement ADT and focal radiation, eligibility, workflow, and access.
Chapters
00:00 How the Immune System Fights Prostate Cancer
02:00 Why dendritic cells matter; generals vs NK/T “soldiers”
07:00 The “double-loading” breakthrough and fail-safe concept
14:00 Trials in difficult cancers; safety and early signals
18:00 Prostate cases: CRPC responses; lesions regressing
22:00 Combining with ADT and focal radiation; timing
27:00 Critical need for viable tissue; preservation tips
34:00 Patient journey: review → tissue + apheresis → 3 doses/6 weeks
41:00 Peri-lymphatic delivery; what patients feel; follow-up/boosts
49:00 Cost, access, insurance help; foundations; closing takeaways
Key Takeaways
________________________
🌱 Partner Offers
ProLon 5-Day Fasting Mimicking Diet → https://bit.ly/3TVehAx
AG1 by Athletic Greens → https://bit.ly/3mA2tVV
💪 Exclusive Membership
Unlock curated transcripts, detailed show notes, expert resources, and perks.
Join here → https://drgeo.com/membership
📌 Follow and Connect
YouTube → https://www.youtube.com/@DrGeoProstatePodcast
All Podcast Episodes → https://dr-geo-prostate-podcast.captivate.fm
Instagram → https://bit.ly/DRGEO-INSTA-YT
Facebook → https://bit.ly/POD-FB-DrGeo
LinkedIn → https://bit.ly/DRGEO-LINKEDIN-YT
XY Wellness Supplements → https://bit.ly/3uJPC7Z
Mr. Happy → https://bit.ly/3TE7tWE
Website → https://bit.ly/43khht0
📣 Hashtags
#DrGeoProstatePodcast #ProstateCancer #ProstateHealth #MensHealth #IntegrativeUrology #SBRT #Oligometastatic #RadiationOncology #PSMAPET #ADT
⚠️ Disclaimer
This episode is for educational purposes only and not medical advice. Always consult with a qualified healthcare provider. Geovanni Espinosa, N.D., assumes no liability for outcomes based on this content.
By Dr. Geo Espinosa4.9
5555 ratings
Dr. Geo speaks with cancer immunologist Matthew Halpert, PhD about Immunocine, a dendritic-cell platform that “double-loads” patient-specific tumor signals to trigger a strong, physiologic immune response. Discussion includes mechanism, prostate cancer cases, how it can complement ADT and focal radiation, eligibility, workflow, and access.
Chapters
00:00 How the Immune System Fights Prostate Cancer
02:00 Why dendritic cells matter; generals vs NK/T “soldiers”
07:00 The “double-loading” breakthrough and fail-safe concept
14:00 Trials in difficult cancers; safety and early signals
18:00 Prostate cases: CRPC responses; lesions regressing
22:00 Combining with ADT and focal radiation; timing
27:00 Critical need for viable tissue; preservation tips
34:00 Patient journey: review → tissue + apheresis → 3 doses/6 weeks
41:00 Peri-lymphatic delivery; what patients feel; follow-up/boosts
49:00 Cost, access, insurance help; foundations; closing takeaways
Key Takeaways
________________________
🌱 Partner Offers
ProLon 5-Day Fasting Mimicking Diet → https://bit.ly/3TVehAx
AG1 by Athletic Greens → https://bit.ly/3mA2tVV
💪 Exclusive Membership
Unlock curated transcripts, detailed show notes, expert resources, and perks.
Join here → https://drgeo.com/membership
📌 Follow and Connect
YouTube → https://www.youtube.com/@DrGeoProstatePodcast
All Podcast Episodes → https://dr-geo-prostate-podcast.captivate.fm
Instagram → https://bit.ly/DRGEO-INSTA-YT
Facebook → https://bit.ly/POD-FB-DrGeo
LinkedIn → https://bit.ly/DRGEO-LINKEDIN-YT
XY Wellness Supplements → https://bit.ly/3uJPC7Z
Mr. Happy → https://bit.ly/3TE7tWE
Website → https://bit.ly/43khht0
📣 Hashtags
#DrGeoProstatePodcast #ProstateCancer #ProstateHealth #MensHealth #IntegrativeUrology #SBRT #Oligometastatic #RadiationOncology #PSMAPET #ADT
⚠️ Disclaimer
This episode is for educational purposes only and not medical advice. Always consult with a qualified healthcare provider. Geovanni Espinosa, N.D., assumes no liability for outcomes based on this content.

7,236 Listeners

735 Listeners

1,576 Listeners

488 Listeners

1,682 Listeners

3,504 Listeners

9,281 Listeners

1,810 Listeners

803 Listeners

72 Listeners

220 Listeners

592 Listeners

573 Listeners

1,164 Listeners

33 Listeners